| Primary |
| Hypertension |
19.0% |
| Carcinoid Tumour |
11.4% |
| Coronary Artery Disease |
10.2% |
| Prophylaxis |
5.7% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Prostate Cancer |
4.6% |
| Diabetes Mellitus |
4.3% |
| Hiv Infection |
4.2% |
| Crohn's Disease |
4.0% |
| Rheumatoid Arthritis |
3.7% |
| Hepatic Neoplasm Malignant |
3.2% |
| Hepatitis C |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Chronic Hepatitis C |
2.9% |
| Pancreatic Neuroendocrine Tumour |
2.9% |
| Insomnia |
2.7% |
| Analgesic Therapy |
2.6% |
| Pain |
2.6% |
| Colitis Ulcerative |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
|
| Abdominal Pain |
13.1% |
| Atrial Fibrillation |
9.5% |
| Urinary Tract Infection |
8.3% |
| Syncope |
7.1% |
| Myocardial Infarction |
6.0% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Femoral Neck Fracture |
4.8% |
| Neoplasm Malignant |
4.8% |
| Neutropenia |
4.8% |
| Pneumonia |
4.8% |
| Pyrexia |
4.8% |
| Renal Failure Chronic |
4.8% |
| Dyspnoea |
3.6% |
| Erysipelas |
3.6% |
| General Physical Health Deterioration |
3.6% |
| Arrhythmia |
2.4% |
| Asthenia |
2.4% |
| Basal Cell Carcinoma |
2.4% |
| Cardiac Arrest |
2.4% |
| Cardiac Failure |
2.4% |
|
| Secondary |
| Rheumatoid Arthritis |
22.8% |
| Crohn's Disease |
11.2% |
| Colitis Ulcerative |
7.8% |
| Type 2 Diabetes Mellitus |
6.9% |
| Hypertension |
6.2% |
| Product Used For Unknown Indication |
5.8% |
| Prophylaxis Of Nausea And Vomiting |
3.8% |
| Acute Coronary Syndrome |
3.8% |
| Prophylaxis |
3.8% |
| Premedication |
3.4% |
| Thrombosis Prophylaxis |
3.2% |
| Hepatic Neoplasm Malignant |
3.0% |
| Diabetes Mellitus |
2.8% |
| Drug Use For Unknown Indication |
2.8% |
| Pain |
2.5% |
| Hiv Infection |
2.3% |
| Hepatitis C |
2.1% |
| Constipation |
2.1% |
| Psoriasis |
1.8% |
| Analgesic Therapy |
1.8% |
|
| Pneumonia |
15.3% |
| Sepsis |
8.9% |
| Vomiting |
8.2% |
| Pyrexia |
7.6% |
| Renal Failure Acute |
6.4% |
| Urinary Tract Infection |
5.3% |
| Pulmonary Tuberculosis |
4.6% |
| Syncope |
4.5% |
| Retinal Vein Occlusion |
4.3% |
| Maternal Exposure During Pregnancy |
4.2% |
| Anal Abscess |
3.6% |
| Septic Shock |
3.5% |
| Tonsillitis |
3.3% |
| Cellulitis |
3.3% |
| Death |
3.2% |
| Myocardial Infarction |
3.2% |
| Basal Cell Carcinoma |
2.7% |
| Breast Cancer |
2.7% |
| Neoplasm Malignant |
2.7% |
| Abscess Limb |
2.7% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
34.7% |
| Product Used For Unknown Indication |
15.3% |
| Hiv Infection |
6.3% |
| Drug Use For Unknown Indication |
5.6% |
| Angina Pectoris |
5.4% |
| Hepatitis C |
4.4% |
| Prophylaxis |
4.1% |
| Rheumatoid Arthritis |
3.1% |
| Myocardial Infarction |
2.9% |
| Pain |
2.7% |
| Hypertension |
2.5% |
| Multiple Myeloma |
2.0% |
| Depression |
1.9% |
| Crohn's Disease |
1.7% |
| Acute Myocardial Infarction |
1.5% |
| Coronary Artery Disease |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Thrombosis Prophylaxis |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Hepatic Neoplasm Malignant |
1.0% |
|
| Therapeutic Procedure |
11.9% |
| Anaemia |
10.9% |
| Pneumonia |
9.9% |
| Vomiting |
8.9% |
| Gastric Ulcer |
5.0% |
| Hypoglycaemia |
5.0% |
| Nephropathy Toxic |
5.0% |
| Thrombocytopenia |
5.0% |
| Toxic Skin Eruption |
5.0% |
| Dyspnoea |
4.0% |
| Renal Failure |
4.0% |
| Renal Failure Acute |
4.0% |
| Acute Myocardial Infarction |
3.0% |
| Aortic Aneurysm |
3.0% |
| Pancreatitis Acute |
3.0% |
| Thrombosis |
3.0% |
| Upper Gastrointestinal Haemorrhage |
3.0% |
| Vascular Pseudoaneurysm |
3.0% |
| Burns Second Degree |
2.0% |
| Delirium |
2.0% |
|
| Interacting |
| Crohn's Disease |
57.7% |
| Type 2 Diabetes Mellitus |
11.5% |
| Acute Myeloid Leukaemia |
9.6% |
| Pancreatic Carcinoma |
9.6% |
| Atrial Fibrillation |
7.7% |
| Product Used For Unknown Indication |
3.8% |
|
| Drug Interaction |
53.8% |
| Small Intestinal Obstruction |
23.1% |
| Rectal Haemorrhage |
15.4% |
| Skin Ulcer |
7.7% |
|
